AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Hands hold a smartphone

More than 80% of physicians use AI professionally: AMA survey

| 4 Min Read
People in a group with stacked hands

Embedding physician well-being into system strategy

| 8 Min Read
Smiling woman works at a laptop

Medicare patients get virtual access to diabetes prevention

| 3 Min Read
Operating room corridor

A more accurate Medicare Advantage provider directory on the way

| 4 Min Read